JNJ-38431055

· Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JNJ-38431055, covering 2009-10-06 to 2014-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus [Phase 1]

See pricing